164 related articles for article (PubMed ID: 30241371)
1. Combined Use of
Dahlizar S; Futaki M; Okada A; Yatomi C; Todo H; Sugibayashi K
Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30241371
[No Abstract] [Full Text] [Related]
2. Design of a Topically Applied Gel Spray Formulation with Ivermectin Using a Novel Low Molecular Weight Gelling Agent, Palmitoyl-Glycine-Histidine, to Treat Scabies.
Dahlizar S; Futaki M; Okada A; Kadhum WR; Todo H; Sugibayashi K
Chem Pharm Bull (Tokyo); 2018; 66(3):327-333. PubMed ID: 29491265
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Palmitoyl-Glycine-Histidine as a Permeation Enhancer for Transdermal Delivery.
Imoto T; Goto M
Langmuir; 2021 Aug; 37(30):8971-8977. PubMed ID: 34242506
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
5. Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin.
Gwak HS; Kim SU; Chun IK
Arch Pharm Res; 2002 Jun; 25(3):392-6. PubMed ID: 12135116
[TBL] [Abstract][Full Text] [Related]
6. Influence of penetration enhancer on drug permeation from volatile formulations.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
[TBL] [Abstract][Full Text] [Related]
7. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties.
Yu M; Ma H; Lei M; Li N; Tan F
Eur J Pharm Biopharm; 2014 Sep; 88(1):92-103. PubMed ID: 24704200
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous penetration of acyclovir through excised hairless mouse and rat skin: effect of vehicle and percutaneous penetration enhancer.
Okamoto H; Muta K; Hashida M; Sezaki H
Pharm Res; 1990 Jan; 7(1):64-8. PubMed ID: 2300538
[TBL] [Abstract][Full Text] [Related]
9. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
10. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Skin Permeation of Idebenone from Lipid Nanoparticles Containing Chemical Penetration Enhancers.
Montenegro L; Santagati LM; Sarpietro MG; Castelli F; Panico A; Siciliano EA; Lai F; Valenti D; Sinico C
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371719
[TBL] [Abstract][Full Text] [Related]
12. Topical delivery of anthramycin II. Influence of binary and ternary solvent systems.
Haque T; Rahman KM; Thurston DE; Hadgraft J; Lane ME
Eur J Pharm Sci; 2018 Aug; 121():59-64. PubMed ID: 29746912
[TBL] [Abstract][Full Text] [Related]
13. Effect of vehicle systems, pH and enhancers on the permeation of highly lipophilic aripiprazole from Carbopol 971P gel systems across human cadaver skin.
Hossain MA; Ahmed SU; Plakogiannis FM
Drug Dev Ind Pharm; 2012 Mar; 38(3):323-30. PubMed ID: 22067044
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
[TBL] [Abstract][Full Text] [Related]
15. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions.
Pireddu R; Sinico C; Ennas G; Schlich M; Valenti D; Murgia S; Marongiu F; Fadda AM; Lai F
Colloids Surf B Biointerfaces; 2018 Feb; 162():8-15. PubMed ID: 29132043
[TBL] [Abstract][Full Text] [Related]
16. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
Cho YA; Gwak HS
Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
[TBL] [Abstract][Full Text] [Related]
18. Effects of vehicles and enhancers on transdermal delivery of clebopride.
Rhee YS; Huh JY; Park CW; Nam TY; Yoon KR; Chi SC; Park ES
Arch Pharm Res; 2007 Sep; 30(9):1155-61. PubMed ID: 17958335
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of ketorolac.
Amrish C; Kumar SP
Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
[TBL] [Abstract][Full Text] [Related]
20. Pluronic lecithin organogel (PLO) of diltiazem hydrochloride: effect of solvents/penetration enhancers on ex vivo permeation.
Parhi R; Suresh P; Pattnaik S
Drug Deliv Transl Res; 2016 Jun; 6(3):243-53. PubMed ID: 26754742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
